These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 8855174)
1. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression. Luscombe C; Pedersen J; Uren E; Locarnini S Hepatology; 1996 Oct; 24(4):766-73. PubMed ID: 8855174 [TBL] [Abstract][Full Text] [Related]
2. Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure. Barraud L; Guerret S; Chevallier M; Borel C; Jamard C; Trepo C; Wild CP; Cova L Hepatology; 1999 Apr; 29(4):1317-23. PubMed ID: 10094981 [TBL] [Abstract][Full Text] [Related]
3. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection. Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Mason WS; Cullen J; Saputelli J; Wu TT; Liu C; London WT; Lustbader E; Schaffer P; O'Connell AP; Fourel I Hepatology; 1994 Feb; 19(2):398-411. PubMed ID: 8294097 [TBL] [Abstract][Full Text] [Related]
5. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Reaiche GY; Le Mire MF; Mason WS; Jilbert AR Virology; 2010 Oct; 406(2):286-92. PubMed ID: 20705309 [TBL] [Abstract][Full Text] [Related]
6. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection. Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150 [TBL] [Abstract][Full Text] [Related]
7. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling]. Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531 [TBL] [Abstract][Full Text] [Related]
8. Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy. Luscombe C; Pedersen J; Bowden S; Locarnini S Liver; 1994 Aug; 14(4):182-92. PubMed ID: 7968278 [TBL] [Abstract][Full Text] [Related]
9. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes]. Yao Y; Tang N; Huang A Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700 [TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology. Zahm FE; Bonino F; Giuseppetti R; Rapicetta M Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):510-6. PubMed ID: 9836108 [TBL] [Abstract][Full Text] [Related]
11. Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes. Schorr O; Borel C; Trepo C; Zoulim F; Hantz O J Hepatol; 2006 May; 44(5):842-7. PubMed ID: 16458387 [TBL] [Abstract][Full Text] [Related]
12. Antiviral effects of PNA in duck hepatitis B virus infection model. Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953 [TBL] [Abstract][Full Text] [Related]
13. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo. Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033 [TBL] [Abstract][Full Text] [Related]
14. In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes. Saade F; Buronfosse T; Guerret S; Pradat P; Chevallier M; Zoulim F; Jamard C; Cova L J Viral Hepat; 2013 Apr; 20(4):e56-65. PubMed ID: 23490390 [TBL] [Abstract][Full Text] [Related]
15. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner. Miller DS; Kotlarski I; Jilbert AR Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of duck hepatitis B virus replication by intrahepatic expression of an antiviral resistance gene. Kündgen LR; Thoma C; Köck J; Wilting J; Koch K; Offensperger WB; Blum HE; von Weizsäcker F J Mol Med (Berl); 2002 Mar; 80(3):187-95. PubMed ID: 11894145 [TBL] [Abstract][Full Text] [Related]
17. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection. Miller DS; Halpern M; Kotlarski I; Jilbert AR Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347 [TBL] [Abstract][Full Text] [Related]
18. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection. Soni PN; Brown D; Saffie R; Savage K; Moore D; Gregoriadis G; Dusheiko GM Hepatology; 1998 Nov; 28(5):1402-10. PubMed ID: 9794928 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro. Delmas J; Schorr O; Jamard C; Gibbs C; Trépo C; Hantz O; Zoulim F Antimicrob Agents Chemother; 2002 Feb; 46(2):425-33. PubMed ID: 11796353 [TBL] [Abstract][Full Text] [Related]
20. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum. Zhao G; Yin Z; Dong J J Ethnopharmacol; 2009 Sep; 125(2):265-8. PubMed ID: 19580857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]